Caribou Biosciences (CRBU) Stock Price, News, Quotes-Moomoo

English
中文繁體
中文简体

Download

Mobile

Moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US Stock MarketDetailed Quotes

CRBU Caribou Biosciences

Watchlist

1.780
-0.160-8.25%

Close Dec 18 16:00 ET

1.840
+0.060+3.35%

Post 20:01 ET

161.18MMarket Cap-1.07P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Caribou Biosciences (CRBU) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
Yahoo FinanceDec 16 09:55 ET
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
BenzingaNov 26 16:06 ET
Caribou Biosciences Analyst Ratings
BenzingaNov 26 10:34 ET · Ratings
Citi Maintains Caribou Biosciences(CRBU.US) With Buy Rating, Cuts Target Price to $6
Moomoo NewsNov 26 07:31 ET · Ratings
Express News | Caribou Biosciences Inc : Citigroup Cuts Target Price to $6 From $30
ReutersNov 26 06:44 ET
Caribou Biosciences Reports Q3 2024 Financial Results
TipRanksNov 21 22:54 ET

Comments

Stock_Drift

Sep 25 08:16

$Caribou Biosciences (CRBU.US)$

FattyChick

Sep 13 12:24

Next 3 stocks keeping an eye on.

$Caribou Biosciences (CRBU.US)$
$Gossamer Bio (GOSS.US)$
$Archer Aviation (ACHR.US)$
Gonna add a position for each again.

Trytosaveabit

Sep 3 07:01

News

$Caribou Biosciences (CRBU.US)$ Reuters· just
Caribou Biosciences Announces the FDA Has Granted Fast Track Designations to CB-010 in Refractory Sle and to CB-012 in Relapsed or Refractory Aml

Jaguar8

Jun 2 20:24

NEWS

$Caribou Biosciences (CRBU.US)$
Caribou Biosciences Presents Encouraging Clinical Data from CB-010 ANTLER Phase 1 Trial in Second-line LBCL Patients at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Caribou Biosciences presented promising clinical data from its CB-010 ANTLER Phase 1 trial at the 2024 ASCO Annual Meeting. CB-010, an allogeneic CAR-T cell therapy with partial HLA matching, showed potential to rival currently approved autologous CAR-T therapies in safety an...

Trytosaveabit

Apr 16 05:31

Hmm?

$Caribou Biosciences (CRBU.US)$ Got a inverted hammer on the daily! Its wick actually broke above the downtrend continuation wedge! Its Really OS RSI 7 = 14.58! RSI 14 = 24.96! MACD Looks as if its fixing to GC? So lets just see how this turns out? Just thinking outloud

Heat List

Overall

No Data

Investment Theme

Gene Editing

Intraday-4.27%